Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
GHRS compared with COAG: revenue, margins and what each company keeps, and the suppliers and customers both name
GHRS
GH Research PLC
Change
Mkt cap
Revenue
Revenue
COAG
Hemab Therapeutics Holdings, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
GHRS
GH Research PLC
vs
COAG
Hemab Therapeutics Holdings, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
GHRS
No earnings history for GHRS.
COAG
1 of 4 reports
Report
implied
realized
× implied
Q2 FY26
—
▲
+3.75%
—
= implied
GHRS realized, solid
COAG realized, hatched
One scale, both sides: full bar = 4%
× = |realized| ÷ implied
Source: market data
GHRS
GH Research PLC
Change
18.56
▲
+0.65%
· post 18.56
Mkt cap
$1.2B
COAG
Hemab Therapeutics Holdings, Inc.
Change
48.95
▲
+7.41%
· post 48.60
Closed
Nov 6 '26
Mkt cap
$1.5B
vs
Compare
Closed
Nov 6 '26
GHRS
GH Research PLC
vs
COAG
Hemab Therapeutics Holdings, Inc.
18.56
▲
+0.65%
post 18.56
Price
48.95
▲
+7.41%
post 48.60
$1.2B
Mkt cap
$1.5B
Change
Change
GHRS
18.56
▲
+0.65%
vs
COAG
48.95
▲
+7.41%
Closed
Nov 6 '26